X
  • News
Advanced Medical Solutions Group plc Logo Advanced Medical Solutions Group plc Logo
  • Home
  • About Us
    • Company
    • Quality and Regulatory
    • Innovation
    • Careers
    • Corporate Social Responsibility
    • Modern Slavery Act
    • Gender Pay Report
    • Sealantis
    • Biomatlante
  • Our Technologies
    • Alginates
    • Collagen
    • Cyanoacrylates
    • Foam
    • Hydrocolloid
    • Hydrogels
    • Internal Sealants
    • Oxidised Cellulose
    • Sutures
  • Our Divisions
    • Surgical
      • LiquiBand®
      • RESORBA®
      • Partners
      • Request Information
    • Woundcare
      • ActivHeal®
      • Foams
      • Hydrogels
      • Hydrocolloids
      • Alginates
      • Film
      • Request Information
      • Downloads
  • Investor Relations
    • At a Glance
    • Our Business
      • Our Vision and Strategy
      • Our Business Model
    • Corporate Governance
      • Corporate Governance
      • Statement of Compliance
      • Engagement with Stakeholders (s172)
      • Board of Directors
      • Board Committees
        • Audit Committee
        • Nomination Committee
        • Remuneration Committee
      • Directors’ Responsibilities
      • Key Performance Indicators
      • Senior Management
    • Shareholder Information
      • AGM
      • AIM Rule 26 Information
      • Warning to Shareholders
      • Shareholder Analysis
      • Financial Calendar
      • Company Documents
      • Advisors
      • Analysts
    • Share Price Information
      • Shareholder Price Data
      • Share Price Calculator
      • Share Terms Glossary
    • Regulatory News (RNS)
    • Financial Reports
      • Annual / Interim Reports
      • Results & Presentations
    • Latest Financial Highlights
    • FAQs
    • RNS Alert Service
  • Contact
    • Our Locations
    • Make an Enquiry
  • Home
  • About Us
    • Company
    • Quality and Regulatory
    • Innovation
    • Careers
    • Corporate Social Responsibility
    • Modern Slavery Act
    • Gender Pay Report
    • Sealantis
    • Biomatlante
  • Our Technologies
    • Alginates
    • Collagen
    • Cyanoacrylates
    • Foam
    • Hydrocolloid
    • Hydrogels
    • Internal Sealants
    • Oxidised Cellulose
    • Sutures
  • Our Divisions
    • Surgical
      • LiquiBand®
      • RESORBA®
      • Partners
      • Request Information
    • Woundcare
      • ActivHeal®
      • Foams
      • Hydrogels
      • Hydrocolloids
      • Alginates
      • Film
      • Request Information
      • Downloads
  • Investor Relations
    • At a Glance
    • Our Business
      • Our Vision and Strategy
      • Our Business Model
    • Corporate Governance
      • Corporate Governance
      • Statement of Compliance
      • Engagement with Stakeholders (s172)
      • Board of Directors
      • Board Committees
        • Audit Committee
        • Nomination Committee
        • Remuneration Committee
      • Directors’ Responsibilities
      • Key Performance Indicators
      • Senior Management
    • Shareholder Information
      • AGM
      • AIM Rule 26 Information
      • Warning to Shareholders
      • Shareholder Analysis
      • Financial Calendar
      • Company Documents
      • Advisors
      • Analysts
    • Share Price Information
      • Shareholder Price Data
      • Share Price Calculator
      • Share Terms Glossary
    • Regulatory News (RNS)
    • Financial Reports
      • Annual / Interim Reports
      • Results & Presentations
    • Latest Financial Highlights
    • FAQs
    • RNS Alert Service
  • Contact
    • Our Locations
    • Make an Enquiry
Home Investor Relations Financial Reports and AGM Results Annual / Interim Reports

Annual / Interim Reports

Financial Information

Within this section we present our financial data. Details of our annual and interim reports will be posted to this site as they become available.

Should you have any questions or queries regarding our financial statements please do not hesitate to contact us.

2020

AGM Notice – 2020

Interim Report – 2020

2019

Annual Report – 2019

Interim Report – 2019

2019 Interim Results Announcement

2018

2018 Preliminary Announcement

Annual Report – 2018

Interim Report – 2018

2017

Annual Report – 2017

Interim Report – 2017

2016

Annual Report – 2016

Interim Report – 2016

2015

Annual Report – 2015

Interim Report – 2015

2014

Annual Report – 2014

Interim Report – 2014

2013

Annual Report – 2013

Interim Report – 2013

2012

Annual Report – 2012

Interim Report – 2012

2011

Annual Report – 2011

Interim Report – 2011

2010

Annual Report – 2010

Interim Report – 2010

2009

Annual Report – 2009

Interim Report – 2009

2008

Annual Report – 2008

Interim Report – 2008

2007

Annual Report – 2007

Interim Report – 2007

2006

Annual Report – 2006

Interim Report – 2006

2005

Annual Report – 2005

Interim Report – 2005

2004

Annual Report – 2004

Interim Report – 2004

2003

Annual Report – 2003

Interim Report – 2003

2002

Annual Report – 2002

Interim Report – 2002

2001

Annual Report – 2001

Interim Report – 2001

2000

Annual Report – 2000

Interim Report – 2000

1999

Annual Report – 1999

  • Investor Relations
    • At a Glance
    • Our Business
      • Our Vision and Strategy
      • Our Business Model
    • Corporate Governance
      • Corporate Governance
      • Statement of Compliance
      • Engagement with Stakeholders (s172)
      • Board of Directors
      • Board Committees
        • Audit Committee
        • Nomination Committee
        • Remuneration Committee
      • Directors' Responsibilities
      • Key Performance Indicators
      • Senior Management
    • Shareholder Information
      • AGM
      • AIM Rule 26 Information
      • Warning to Shareholders
      • Shareholder Analysis
      • Financial Calendar
      • Company Documents
      • Our Advisors
      • Our Analysts
    • Share Price Information
      • Shareholder Price Data
      • Share Price Calculator
      • Glossary of Share Price Terms
    • Regulatory News Announcements (RNS)
    • Financial Reports and AGM Results
      • Annual / Interim Reports
      • Results and Presentations
    • Latest Financial Highlights
    • Frequently Asked Questions
    • RNS News Alert Service
    • Share Price
    • Regulatory News
    LSE (UK)

    Advanced Medical Solutions Group Plc trade on the LSE:AIM (symbol: AMS)

    235.00p 1.51%

    At 06:58pm GMT 26th February 2021

    Data delayed at least 15 minutes

    View More Share Information Investor Relations Page
    Total Voting Rights

    Total Voting Rights

    29th January 2021
    Holding(s) in Company

    Holding in Company

    22nd January 2021
    Directorate Change

    Re Directorate

    12th January 2021

    View All RNS

    Not sure what you are looking for? Why not Contact Us and we'll see if we can assist you further.

    About us
    • Company
    • Careers
    • Our Brands
    • Corporate Social Responsibility
    • Modern Slavery Act
    • Gender Pay Report
    • Sealantis
    • Biomatlante
    • Raleigh Coatings
    Our Divisions
    • Surgical
    • Woundcare
    Investor Relations
    • Our Business
    • Corporate Governance
    • Shareholder Information
    • Shareholder Privacy Notice
    • Share Price Information
    • Financial Reports
    • Notice of AGM
    • Proxy Card
    Contact
    • Our Locations
    • Make an Enquiry
    • Sitemap
    • Privacy Policy
    • COVID-19
    © 2021 Advanced Medical Solutions Group plc
    • | Cookies
    • | Accessibility
    • | Disclaimer
    • | Terms and Conditions
    Advanced Medical Solutions Group plc Logo